title: Discrepancies between Patients' Preferences and Educational Programs on Oral Anticoagulant Therapy: A Survey in Community Pharmacies and Hospital Consultations.
abstract: BACKGROUND
  Oral anticoagulation therapy is increasingly used for the prevention and treatment of thromboembolic complications in various clinical situations. Nowadays, education programs for patients treated with anticoagulants constitute an integrated component of their management. However, such programs are usually based on the healthcare providers' perceptions of what patients should know, rather than on patients' preferences.
  
  
  OBJECTIVE
  To investigate patients' viewpoints on educational needs and preferred modalities of information delivery.
  
  
  METHODS
  We conducted an observational study based on a self-administered questionnaire. To explore several profiles of patients, the study was designed for enrolling patients in two settings: during outpatient consultations in a cardiology department (Saint Antoine Hospital, Paris, France) and in community pharmacies throughout France.
  
  
  RESULTS
  Of the 371 patients who completed the questionnaire, 187 (50.4%) were recruited during an outpatient consultation and 184 (49.6%) were recruited in community pharmacies. 84.1% of patients were receiving a vitamin K antagonist and 15.6% a direct oral anticoagulant. Patients ranked 16 of 21 (76.2%) questionnaire items on information about their treatment as important or essential; information on adverse effects of treatment was the highest ranked domain (mean score 2.38, 95% CI 2.30-2.46). Pharmacists (1.69, 1.58-1.80), nurses (1.05, 0.95-1.16), and patient associations (0.36, 0.29-0.44), along with group sessions (0.85, 0.75-0.95), the internet (0.77, 0.67-0.88), and delivery of material at the patient's home (1.26, 1.14-1.38), were ranked poorly in terms of delivering educational material.
  
  
  CONCLUSIONS
  This study revealed substantial discrepancies between patient preferences and current educational programs. These findings should be useful for tailoring future educational programs that are better adapted to patients, with a potential associated enhancement of their effectiveness.
authors.affiliation: AP-HP, Hôpital Saint-Antoine, Service de Pharmacie, Paris, France.
authors.forename: Diane
authors.initials: D
authors.lastname: Macquart de Terline
authors.affiliation: Sorbonne Universités, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.
authors.forename: Gilles
authors.initials: G
authors.lastname: Hejblum
authors.affiliation: AP-HP, Hôpital Saint-Antoine, Service de Pharmacie, Paris, France.|Sorbonne Universités, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.|Univ Paris-Sud, Faculté de Pharmacie, Chatenay-Malabry, France.
authors.forename: Christine
authors.initials: C
authors.lastname: Fernandez
authors.affiliation: AP-HP, Hôpital Saint-Antoine, Service de Cardiologie, Paris, France.
authors.forename: Ariel
authors.initials: A
authors.lastname: Cohen
authors.affiliation: AP-HP, Hôpital Saint-Antoine, Service de Pharmacie, Paris, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Antignac
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D008875:Middle Aged; D010297:Paris / Q000453:epidemiology; D010353:Patient Education as Topic; D057240:Patient Preference; D010594:Pharmacies; D012017:Referral and Consultation; D057566:Self Report; D011795:Surveys and Questionnaires
chemical_list: D000925:Anticoagulants